Concord Biotech informs about investor presentation

09 Feb 2024 Evaluate
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has informed that investor’s presentation on Financial Results for the Third quarter and Nine months ended December 31, 2023 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1524.25 -33.80 (-2.17%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...